(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
about
Profiling of the Chromatin-associated Proteome Identifies HP1BP3 as a Novel Regulator of Cell Cycle ProgressionGastric cancer: The times they are a-changin'Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.Antitumor immunity induced after α irradiationImpact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.Radioimmunotherapy with α-particle-emitting radionuclides.Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.Molecular pathways: targeted α-particle radiation therapy.Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.Methodology for labeling proteins and peptides with lead-212 (212Pb)212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint.Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor XenograftsEvaluation of platinum chemotherapy in combination with HER2-targeted α-particle radiationPersonalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapiesGene expression profiling upon (212) Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model.Radioimmunotherapy for peritoneal cancers.Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease.Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.Alpha Particles Induce Autophagy in Multiple Myeloma Cells.Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
P2860
Q24297847-5930EAED-6F08-43C2-B163-CE84BCCFDFFFQ26776195-10476A4F-8792-44EC-84EC-7E01741A3DABQ33761180-BBB20E38-5A68-49E5-80EA-86012CFE0255Q33891246-ABC4F011-EEBA-4747-AEE0-9E901D9B315EQ34277296-94E52EDC-D0A6-4D63-AFB9-830E9CF058C4Q34419562-93D51433-A3B0-4584-975D-81DFFA59FC35Q36088727-0DED8885-DAB0-48F4-927D-CFEC7042232BQ36105801-348C56CF-CD90-4461-951E-1DF654A8391EQ36213374-74229197-BD54-4764-8687-3DE2B6B0D9F7Q36551498-8228EE1E-28B4-48F6-8EF3-2AF936A59BF1Q36585767-600E6581-1259-4C93-8F4F-106A44B3BC56Q36674828-DB3977D3-7DF6-4158-94A3-EDA080E0942FQ36881360-5B79F150-16DB-40CB-8664-2D1E57707195Q36896084-429A541F-3DA8-4AE5-A4DB-E41E71C65D8EQ36939290-A582F2FD-DEA9-470B-8D5B-AEFE78455026Q37025617-DF4BFBC1-16B2-41B3-B4C1-76287CCB886EQ37241496-B837F4AC-F13D-4B38-8223-84F7D2589291Q37482554-9A82A876-4EC0-4714-B13F-C1FC8B820ADBQ38096059-979D61E5-832A-4341-A243-A7A2C8FE134AQ38663041-097821F4-0B7E-420F-B2D1-D3BFEA3B5E8FQ39300912-62CD6835-6105-4BEA-99C4-7CDFB430B263Q43214199-FA349DF6-D1A8-486A-B1B8-616057783DE6Q50149863-32A33A95-AD0E-42B6-907D-BFA372AD2FF2
P2860
(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@ast
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@en
type
label
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@ast
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@en
prefLabel
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@ast
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@en
P2093
P2860
P1476
(212)Pb-radioimmunotherapy ind ...... nated intraperitoneal disease.
@en
P2093
Diane E Milenic
Kwamena E Baidoo
Kwon Joong Yong
Martin W Brechbiel
P2860
P304
P356
10.1158/1535-7163.MCT-11-0671
P577
2012-01-11T00:00:00Z